US Stock MarketDetailed Quotes

BIOR Biora Therapeutics

Watchlist

0.4965
-0.0051-1.02%

Close Oct 1 16:00 ET

0.4999
+0.0034+0.68%

Post 18:22 ET

18.11MMarket Cap-100P/E (TTM)

Biora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

15,800.00%318K

27,000.00%542K

-98.69%4K

-98.08%2K

-98.13%2K

-75.54%305K

-96.78%14K

-56.04%80K

Operating revenue

15,800.00%318K

27,000.00%542K

-98.69%4K

--0

-98.08%2K

-98.13%2K

-75.54%305K

-96.78%14K

-56.04%80K

Cost of revenue

Gross profit

Operating expense

7.82%16.1M

3.29%16.06M

8.15%67.15M

-3.23%13.34M

66.97%23.32M

4.35%14.94M

-22.33%15.55M

-47.86%62.09M

-33.04%13.79M

-54.57%13.97M

Selling and administrative expenses

-6.18%8.4M

8.34%9.05M

-1.91%37.31M

-9.93%7.23M

56.79%12.77M

6.46%8.95M

-37.91%8.36M

-48.11%38.04M

-33.74%8.02M

-56.00%8.15M

Research and development costs

28.76%7.7M

-2.57%7.01M

24.07%29.84M

6.09%6.12M

81.22%10.55M

1.34%5.98M

9.64%7.19M

-47.47%24.05M

-32.03%5.77M

-52.40%5.82M

Operating profit

-5.71%-15.79M

0.18%-15.52M

-8.68%-67.14M

3.14%-13.34M

-67.93%-23.32M

-5.10%-14.93M

21.92%-15.54M

47.57%-61.78M

31.66%-13.78M

54.56%-13.89M

Net non-operating interest income expense

73.70%-711K

-2.87%-2.76M

10.69%-9.82M

31.47%-1.84M

6.53%-2.59M

2.49%-2.7M

2.90%-2.68M

13.03%-10.99M

-22.83%-2.69M

19.81%-2.77M

Non-operating interest expense

-73.70%711K

2.87%2.76M

-10.69%9.82M

-31.47%1.84M

-6.53%2.59M

-2.49%2.7M

-2.90%2.68M

-13.03%10.99M

22.83%2.69M

-19.81%2.77M

Other net income (expense)

13,892.17%22.9M

1,704.85%14.13M

-301.80%-47.47M

-116.70%-543K

-2,545.47%-47.54M

-101.64%-166K

-90.43%783K

148.83%23.52M

105.37%3.25M

168.09%1.94M

Gain on sale of security

8,176.40%13M

1,510.53%13.92M

-13.87%18M

133.29%12.73M

123.48%4.57M

-103.65%-161K

-90.39%864K

138.60%20.9M

111.29%5.46M

161.53%2.04M

Other non- operating income (expenses)

197,940.00%9.89M

367.90%217K

-2,601.72%-65.47M

-501.54%-13.28M

-52,008.00%-52.11M

-100.09%-5K

90.01%-81K

-56.31%2.62M

81.94%-2.21M

-121.41%-100K

Income before tax

135.94%6.4M

76.26%-4.14M

-152.64%-124.42M

-19.05%-15.73M

-399.14%-73.45M

-160.51%-17.8M

-20.37%-17.44M

72.43%-49.25M

84.07%-13.21M

60.09%-14.72M

Income tax

-1,775.00%-67K

48K

78.57%-90K

-136.68%-95K

-99.37%1K

100.48%4K

-252.94%-420K

317.65%259K

158K

Net income

136.31%6.47M

75.98%-4.19M

-225.27%-124.12M

-12.32%-15.41M

-1,336.33%-73.45M

-223.00%-17.81M

-26.31%-17.44M

84.58%-38.16M

85.22%-13.72M

88.31%-5.11M

Net income continuous Operations

136.31%6.47M

75.98%-4.19M

-154.63%-124.33M

-16.06%-15.63M

-393.84%-73.45M

-196.93%-17.81M

-20.37%-17.44M

72.65%-48.83M

83.73%-13.47M

59.66%-14.87M

Net income discontinuous operations

----

-97.95%219K

186.56%219K

--0

----

115.49%10.67M

97.49%-253K

242.07%9.76M

Minority interest income

Net income attributable to the parent company

136.31%6.47M

75.98%-4.19M

-225.27%-124.12M

-12.32%-15.41M

-1,336.33%-73.45M

-223.00%-17.81M

-26.31%-17.44M

84.58%-38.16M

85.22%-13.72M

88.31%-5.11M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

136.31%6.47M

75.98%-4.19M

-225.27%-124.12M

-12.32%-15.41M

-1,336.33%-73.45M

-223.00%-17.81M

-26.31%-17.44M

84.58%-38.16M

85.22%-13.72M

88.31%-5.11M

Basic earnings per share

112.24%0.18

91.19%-0.14

93.70%-7.87

99.94%-0.62

-619.12%-4.89

-96.00%-1.47

15.43%-1.59

99.69%-125

-7,221.43%-1.03K

94.09%-0.68

Diluted earnings per share

97.28%-0.04

91.19%-0.14

93.70%-7.87

99.94%-0.62

-619.12%-4.89

-96.00%-1.47

15.43%-1.59

99.69%-125

-7,221.43%-1.03K

94.09%-0.68

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	15,800.00%318K	27,000.00%542K	-98.69%4K	0	0	-98.08%2K	-98.13%2K	-75.54%305K	-96.78%14K	-56.04%80K
Operating revenue	15,800.00%318K	27,000.00%542K	-98.69%4K	--0	--0	-98.08%2K	-98.13%2K	-75.54%305K	-96.78%14K	-56.04%80K
Cost of revenue
Gross profit
Operating expense	7.82%16.1M	3.29%16.06M	8.15%67.15M	-3.23%13.34M	66.97%23.32M	4.35%14.94M	-22.33%15.55M	-47.86%62.09M	-33.04%13.79M	-54.57%13.97M
Selling and administrative expenses	-6.18%8.4M	8.34%9.05M	-1.91%37.31M	-9.93%7.23M	56.79%12.77M	6.46%8.95M	-37.91%8.36M	-48.11%38.04M	-33.74%8.02M	-56.00%8.15M
Research and development costs	28.76%7.7M	-2.57%7.01M	24.07%29.84M	6.09%6.12M	81.22%10.55M	1.34%5.98M	9.64%7.19M	-47.47%24.05M	-32.03%5.77M	-52.40%5.82M
Operating profit	-5.71%-15.79M	0.18%-15.52M	-8.68%-67.14M	3.14%-13.34M	-67.93%-23.32M	-5.10%-14.93M	21.92%-15.54M	47.57%-61.78M	31.66%-13.78M	54.56%-13.89M
Net non-operating interest income expense	73.70%-711K	-2.87%-2.76M	10.69%-9.82M	31.47%-1.84M	6.53%-2.59M	2.49%-2.7M	2.90%-2.68M	13.03%-10.99M	-22.83%-2.69M	19.81%-2.77M
Non-operating interest expense	-73.70%711K	2.87%2.76M	-10.69%9.82M	-31.47%1.84M	-6.53%2.59M	-2.49%2.7M	-2.90%2.68M	-13.03%10.99M	22.83%2.69M	-19.81%2.77M
Other net income (expense)	13,892.17%22.9M	1,704.85%14.13M	-301.80%-47.47M	-116.70%-543K	-2,545.47%-47.54M	-101.64%-166K	-90.43%783K	148.83%23.52M	105.37%3.25M	168.09%1.94M
Gain on sale of security	8,176.40%13M	1,510.53%13.92M	-13.87%18M	133.29%12.73M	123.48%4.57M	-103.65%-161K	-90.39%864K	138.60%20.9M	111.29%5.46M	161.53%2.04M
Other non- operating income (expenses)	197,940.00%9.89M	367.90%217K	-2,601.72%-65.47M	-501.54%-13.28M	-52,008.00%-52.11M	-100.09%-5K	90.01%-81K	-56.31%2.62M	81.94%-2.21M	-121.41%-100K
Income before tax	135.94%6.4M	76.26%-4.14M	-152.64%-124.42M	-19.05%-15.73M	-399.14%-73.45M	-160.51%-17.8M	-20.37%-17.44M	72.43%-49.25M	84.07%-13.21M	60.09%-14.72M
Income tax	-1,775.00%-67K	48K	78.57%-90K	-136.68%-95K	-99.37%1K	100.48%4K	0	-252.94%-420K	317.65%259K	158K
Net income	136.31%6.47M	75.98%-4.19M	-225.27%-124.12M	-12.32%-15.41M	-1,336.33%-73.45M	-223.00%-17.81M	-26.31%-17.44M	84.58%-38.16M	85.22%-13.72M	88.31%-5.11M
Net income continuous Operations	136.31%6.47M	75.98%-4.19M	-154.63%-124.33M	-16.06%-15.63M	-393.84%-73.45M	-196.93%-17.81M	-20.37%-17.44M	72.65%-48.83M	83.73%-13.47M	59.66%-14.87M
Net income discontinuous operations	----	----	-97.95%219K	186.56%219K	--0	----	----	115.49%10.67M	97.49%-253K	242.07%9.76M
Minority interest income
Net income attributable to the parent company	136.31%6.47M	75.98%-4.19M	-225.27%-124.12M	-12.32%-15.41M	-1,336.33%-73.45M	-223.00%-17.81M	-26.31%-17.44M	84.58%-38.16M	85.22%-13.72M	88.31%-5.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	136.31%6.47M	75.98%-4.19M	-225.27%-124.12M	-12.32%-15.41M	-1,336.33%-73.45M	-223.00%-17.81M	-26.31%-17.44M	84.58%-38.16M	85.22%-13.72M	88.31%-5.11M
Basic earnings per share	112.24%0.18	91.19%-0.14	93.70%-7.87	99.94%-0.62	-619.12%-4.89	-96.00%-1.47	15.43%-1.59	99.69%-125	-7,221.43%-1.03K	94.09%-0.68
Diluted earnings per share	97.28%-0.04	91.19%-0.14	93.70%-7.87	99.94%-0.62	-619.12%-4.89	-96.00%-1.47	15.43%-1.59	99.69%-125	-7,221.43%-1.03K	94.09%-0.68
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data